DaVita (DVA) stock in plain English
Every company we rate gets Strong Buy, Buy, Buy with Caution, Hold or Sell. Members see the rating for this company and the five scores behind it.
Change shown by the quote provider. Data may be delayed.
What does DaVita (DVA) do?
DaVita Inc (DVA) is a U.S.-listed company in Healthcare (Medical Care Facilities). What it does: Delivers kidney dialysis services and related lab testing across outpatient clinics and patient homes. Operates thousands of outpatient clinics providing specialized dialysis care to patients with chronic kidney failure. It is worth $9.83B on the market and sold $14.25B over the last year.
- Market cap
- $9.83B
- P/E ratio
- 11.8×
- Annual sales
- $14.25B
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- Brief updated
- Nov 16, 2026
DVA’s flags, in plain English
Each flag is a number from DaVita’s reports to the SEC or from market data, with the reason it matters. This brief was updated on Nov 16, 2026.
Growth vs Price
The price looks reasonable for how fast it is growing. The price looks reasonable for how fast its profits are growing.
Cheap on Cash Flow
Priced at 7.6 times the cash it generates each year. The share price is low compared with the cash the business actually brings in, and cash is harder to dress up than profit.
Earnings Jumping
Profits up 37.6% this year. Profit per share is growing fast this year. One year does not make a trend, so check whether sales grew too.
Growth Cooling
Sales growth slowed to 3.4% a year over 5 years. Sales are growing more slowly than before, which makes the current share price harder to justify.
1 more green flag open with the free trial. Try it free for 7 days.
Questions about DVA
How big is DaVita?
DaVita’s market cap is $9.83B: what all of its shares are worth together at today’s price. Its annual sales (revenue) are $14.25B: what customers paid the company over the last year, before any costs.
What is DVA’s P/E ratio?
DVA’s P/E ratio is 11.8×. Investors pay about 11.8 dollars for each dollar of the company’s yearly profit. A low number can mean a bargain or a problem, so read it next to the flags.
What could go wrong with DVA?
Federal Medicare reimbursement rate limits directly restrict revenue growth while clinical labor wages remain elevated. That is one risk on DaVita’s card. Its first risk flag is Growth Cooling, explained above. A flag reads what the company reported. It does not predict the price.
Where do these numbers come from?
From DaVita’s own reports to the SEC (annual and quarterly) and from market data. Every company runs through the same scoring formula, and a reviewer spot-checks cards against the source data. DVA’s filings on SEC.gov. The Margin Monkey is research, not advice.
